Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021)
Cardiol Therapeutics (CRDL) posted Depreciation & Amortization - Total of $27261.3 for Q2 2021, up 4.03% on a QoQ basis from $26206.4 in Q2 2020, and up 4.03% year-over-year from $26206.4 in Q2 2020.
Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021) Analysis & Trends
Cardiol Therapeutics' Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at $27261.3 for Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 27,261.30 |
| Jun 30, 2020 | 26,206.39 |